172 related articles for article (PubMed ID: 5546195)
1. Variation of dihydrofolate reductase activity during in vitro and in vivo growth of sublines of L1210 lymphoma.
Hillcoat BL
J Natl Cancer Inst; 1971 Jan; 46(1):75-80. PubMed ID: 5546195
[No Abstract] [Full Text] [Related]
2. Effects of perfusion with amethopterin on L1210 leukemia cells in spin filter culture.
Thayer PS; Himmelfarb P; Roberts D
Cancer Res; 1970 Jun; 30(6):1709-14. PubMed ID: 5457937
[No Abstract] [Full Text] [Related]
3. Interaction of thymidylate synthetase and dihydrofolate reductase enzymes in vitro and in vivo.
Kawai M; Hillcoat BL
Cancer Res; 1974 Jul; 34(7):1619-26. PubMed ID: 4833915
[No Abstract] [Full Text] [Related]
4. Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo.
Sirotnak FM; Moccio DM; Kelleher LE; Goutas LJ
Cancer Res; 1981 Nov; 41(11 Pt 1):4447-52. PubMed ID: 7306968
[TBL] [Abstract][Full Text] [Related]
5. Utilization of an immunostaining technique to demonstrate heterogeneity in the content of dihydrofolate reductase in peripheral blast cells from a patient with acute lymphocytic leukemia.
Grill SP; Wells RJ; Cheng YC
Cancer Res; 1984 Mar; 44(3):1252-6. PubMed ID: 6581868
[TBL] [Abstract][Full Text] [Related]
6. Dihydrofolate reductase from a resistant subline of the L1210 lymphoma. Purification and properties.
Perkins JP; Hillcoat BL; Bertino JR
J Biol Chem; 1967 Oct; 242(20):4771-6. PubMed ID: 4964810
[No Abstract] [Full Text] [Related]
7. Properties of dihydrofolate reductase from a methotrexate-resistant subline of human KB cells and comparison with enzyme from KB parent cells and mouse S180 AT/3000 cells.
Domin BA; Cheng YC; Hakala MT
Mol Pharmacol; 1982 Jan; 21(1):231-8. PubMed ID: 7132960
[No Abstract] [Full Text] [Related]
8. Hybridization of actinomycin D- and amethopterin-resistant Chinese hamster cells in vitro.
Sobel JS; Albrecht AM; Riehm H; Biedler JL
Cancer Res; 1971 Mar; 31(3):297-307. PubMed ID: 5547219
[No Abstract] [Full Text] [Related]
9. Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cells.
Chu BC; Fan CC; Howell SB
J Natl Cancer Inst; 1981 Jan; 66(1):121-4. PubMed ID: 6935452
[TBL] [Abstract][Full Text] [Related]
10. Establishment of dihydrofolate reductase-increased human cell lines and relationship between dihydrofolate reductase levels and gene copy.
Domin BA; Grill SP; Cheng Y
Cancer Res; 1983 May; 43(5):2155-8. PubMed ID: 6831441
[TBL] [Abstract][Full Text] [Related]
11. Lack of intracellular conversion of dihydrohomofolate to tetrahydrohomofolate in leukemia cells with high levels of dihydrofolate reductase.
Nahas A; Friedkin M
Mol Pharmacol; 1972 May; 8(3):353-61. PubMed ID: 5040933
[No Abstract] [Full Text] [Related]
12. Loss of resistance to methotrexate in L5178Y mouse leukemia grown in vitro.
Courtenay VD; Robins AB
J Natl Cancer Inst; 1972 Jul; 49(1):45-53. PubMed ID: 5037439
[No Abstract] [Full Text] [Related]
13. Dihydrofolate reductase activity and loss of resistance in an antifolate-resistant subline of leukemia L1210 after discontinuation of treatment.
Schrecker AW; Mead JA; Greenberg NH; Goldin A
Chem Biol Interact; 1970 Oct; 2(3):229-34. PubMed ID: 5289825
[No Abstract] [Full Text] [Related]
14. Substrate and inhibitor complexes of dihydrofolate reductase from amethopterin-resistant L1210 cells.
Neef VG; Huennekens FM
Arch Biochem Biophys; 1975 Dec; 171(2):435-43. PubMed ID: 959
[No Abstract] [Full Text] [Related]
15. Dihydrofolate reductase from the L1210 R murine lymphoma. Further studies on the binding of substrates and inhibitors to the enzyme.
Hillcoat BL; Perkins JP; Bertino JR
J Biol Chem; 1967 Oct; 242(20):4777-81. PubMed ID: 4383525
[No Abstract] [Full Text] [Related]
16. Biochemical correlates of responsiveness and collateral sensitivity of some methotrexate-resistant murine tumors to the lipophilic antifolate, metoprine.
Sirotnak FM; Moccio DM; Goutas LJ; Kelleher LE; Montgomery JA
Cancer Res; 1982 Mar; 42(3):924-8. PubMed ID: 7059991
[TBL] [Abstract][Full Text] [Related]
17. Stabilization of dihydrofolate reductase by inhibitors in vivo and in vitro.
Hillcoat BL; Marshall L; Gauldie J; Hiebert M
Ann N Y Acad Sci; 1971 Nov; 186():187-208. PubMed ID: 4332034
[No Abstract] [Full Text] [Related]
18. Limited effectiveness of in vitro high-dose methotrexate and leucovorin to overcome resistance in L1210 leukemia cells with elevations of dihydrofolate reductase.
Bruckner H; Rubinoff M; Waxman S
Eur J Cancer (1965); 1980 Aug; 16(8):1057-63. PubMed ID: 6969180
[No Abstract] [Full Text] [Related]
19. Amethopterin-induced changes in the multiple forms of dihydrofolate reductase from L1210 cells.
Harding NG; Martelli MF; Huennekens FM
Arch Biochem Biophys; 1970 Mar; 137(1):295-6. PubMed ID: 5435066
[No Abstract] [Full Text] [Related]
20. The intracellular concentration dependence of antifolate inhibition of DNA synthesis in L1210 leukemia cells.
Sirotnak FM; Donsbach RC
Cancer Res; 1974 Dec; 34(12):332-40. PubMed ID: 4429954
[No Abstract] [Full Text] [Related]
[Next] [New Search]
